Nantahala Capital Management »

Acasti Pharma shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.5M 1.2M 2.98
2025-06-30 $3.5M 1.2M 2.97
2025-03-31 $2.7M 1.2M 2.28

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Acasti Pharma

Nantahala Capital Management
AIGH Capital Management
Vanguard Group
ADAR1 Capital Management
Stonepine Capital Management
Renaissance Technologies
Citadel Advisors
Millington Financial Advisors
Stratos Wealth Partners
National Bank Of Canada /fi/
Tower Research Capital
Royal Bank of Canada
Activest Wealth Management
SBI Securities
Steward Partners Investment Advisory

View all funds holding Acasti Pharma